Administration of gonadotrophin-releasing hormone (GnRH) analogue (leading to amenorrhea), in the immediate postoperative period, for 6–12 months is suggested for all patients with proven catamenial and/ or endometriosis-related pneumothorax. Here, GNRH1 is linked to endometriosis.